{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:59:30Z","timestamp":1794545970945,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["No A-12-1757-9."],"award-info":[{"award-number":["No A-12-1757-9."]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["No A-12-1757-9."],"award-info":[{"award-number":["No A-12-1757-9."]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["No A-12-1757-9."],"award-info":[{"award-number":["No A-12-1757-9."]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["No A-12-1757-9."],"award-info":[{"award-number":["No A-12-1757-9."]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008323","name":"Zanjan University of Medical Sciences","doi-asserted-by":"publisher","award":["No A-12-1757-9."],"award-info":[{"award-number":["No A-12-1757-9."]}],"id":[{"id":"10.13039\/501100008323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10528-025-11193-1","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:47:26Z","timestamp":1753264046000},"page":"4493-4512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Prognostic-Related Genes in Acute Myeloid Leukemia: A Study Based on TCGA Data Analysis"],"prefix":"10.1007","volume":"64","author":[{"given":"Fatemeh Sadat","family":"Shafiei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Abroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Vahdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Arash","family":"Anoushirvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"10","key":"11193_CR1","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/10428194.2024.2360536","volume":"65","author":"LJ Anderson","year":"2024","unstructured":"Anderson LJ, Girguis M, Kim E, Shewale J, Braunlin M, Werther W et al (2024) A temporal and multinational assessment of acute myeloid leukemia (AML) cancer incidence, survival, and disease burden. Leuk Lymphoma 65(10):1482\u20131492","journal-title":"Leuk Lymphoma"},{"key":"11193_CR2","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1200\/JCO.2021.39.15_suppl.5561","volume":"39","author":"H Atiya","year":"2021","unstructured":"Atiya H, Orellana T, Coffman LG (2021) Role of CD10 expression in endometriosis-associated mesenchymal stem cells on the progression of endometriosis-associated carcinoma. J Clin Oncol 39:5561","journal-title":"J Clin Oncol"},{"issue":"5","key":"11193_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","volume":"19","author":"M Berdasco","year":"2010","unstructured":"Berdasco M, Esteller M (2010) Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 19(5):698\u2013711","journal-title":"Dev Cell"},{"issue":"10","key":"11193_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/modpathol.3800174","volume":"17","author":"N Bilalovic","year":"2004","unstructured":"Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE (2004) CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 17(10):1251\u20131258","journal-title":"Mod Pathol"},{"issue":"4","key":"11193_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cll.2017.07.003","volume":"37","author":"X Chen","year":"2017","unstructured":"Chen X, Cherian S (2017) Acute myeloid leukemia immunophenotyping by flow cytometric analysis. Clin Lab Med 37(4):753\u2013769","journal-title":"Clin Lab Med"},{"issue":"8","key":"11193_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1182\/blood.2019004260","volume":"138","author":"S Chen","year":"2021","unstructured":"Chen S, Benbarche S, Abdel-Wahab O (2021) Splicing factor mutations in hematologic malignancies. Blood 138(8):599\u2013612","journal-title":"Blood"},{"issue":"4","key":"11193_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/CBM-220179","volume":"36","author":"P Chen","year":"2023","unstructured":"Chen P, Cao J, Chen L, Gao G, Xu Y, Jia P et al (2023) Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases. Cancer Biomark 36(4):287\u2013298","journal-title":"Cancer Biomark"},{"key":"11193_CR8","doi-asserted-by":"publisher","first-page":"103175","DOI":"10.1155\/2014\/103175","volume":"2014","author":"E Conway O\u2019Brien","year":"2014","unstructured":"Conway O\u2019Brien E, Prideaux S, Chevassut T (2014) The epigenetic landscape of acute myeloid leukemia. Adv Hematol 2014:103175","journal-title":"Adv Hematol"},{"key":"11193_CR9","first-page":"1","volume":"7","author":"MA Dall\u2019Era","year":"2007","unstructured":"Dall\u2019Era MA, True LD, Siegel AF, Porter MP, Sherertz TM, Liu AY (2007) Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol 7:1\u201311","journal-title":"BMC Urol"},{"issue":"3","key":"11193_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403","journal-title":"Cancer Cell"},{"issue":"7","key":"11193_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.humpath.2006.02.024","volume":"37","author":"L Deschamps","year":"2006","unstructured":"Deschamps L, Handra-Luca A, O\u2019Toole D, Sauvanet A, Ruszniewski P, Belghiti J et al (2006) CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival. Hum Pathol 37(7):802\u2013808","journal-title":"Hum Pathol"},{"issue":"2","key":"11193_CR12","first-page":"85","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Wei AH (2020) How I treat acute myeloid leukemia in the era of new drugs. Blood, J Am Soc Hematol 135(2):85\u201396","journal-title":"Blood, J Am Soc Hematol"},{"key":"11193_CR13","first-page":"36","volume":"1","author":"H D\u00f6hner","year":"2011","unstructured":"D\u00f6hner H, Gaidzik VI (2011) 2011 Impact of genetic features on treatment decisions in AML. Hematol 2010, Am Soc Hematol Educ Progr Book 1:36\u201342","journal-title":"Hematol 2010, Am Soc Hematol Educ Progr Book"},{"key":"11193_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00428-011-1084-z","volume":"458","author":"A Fleischmann","year":"2011","unstructured":"Fleischmann A, Rocha C, Saxer-Sekulic N, Zlobec I, Sauter G, Thalmann GN (2011) High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death. Virchows Arch 458:741\u2013748","journal-title":"Virchows Arch"},{"key":"11193_CR15","doi-asserted-by":"publisher","first-page":"3037337","DOI":"10.1155\/2021\/3037337","volume":"2021","author":"C Fu","year":"2021","unstructured":"Fu C, Yuan M, Sun J, Liu G, Zhao X, Chang W et al (2021) RNA-binding motif protein 11 (RBM11) serves as a prognostic biomarker and promotes ovarian cancer progression. Dis Markers 2021:3037337","journal-title":"Dis Markers"},{"issue":"1","key":"11193_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40001-023-01060-3","volume":"28","author":"Y Gao","year":"2023","unstructured":"Gao Y, Jia Y, Yu Z, Ji X, Liu X, Han L et al (2023) Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database. Eur J Med Res 28(1):103","journal-title":"Eur J Med Res"},{"key":"11193_CR17","doi-asserted-by":"crossref","unstructured":"Genomic and epigenomic landscapes of adult De Novo acute myeloid leukemia. New Eng J Med 2013;368(22):2059\u201374","DOI":"10.1056\/NEJMoa1301689"},{"key":"11193_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-8722-2-23","volume":"2","author":"TK Gregory","year":"2009","unstructured":"Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W (2009) Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol 2:23","journal-title":"J Hematol Oncol"},{"issue":"4","key":"11193_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1200\/JCO.22.00715","volume":"41","author":"T Grob","year":"2023","unstructured":"Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW et al (2023) Prognostic value of FLT3-Internal tandem duplication residual disease in acute myeloid leukemia. J Clin Oncol 41(4):756\u2013765","journal-title":"J Clin Oncol"},{"key":"11193_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-002-0639-4","volume":"440","author":"K Iwaya","year":"2002","unstructured":"Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K (2002) Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 440:589\u2013593","journal-title":"Virchows Arch"},{"issue":"3","key":"11193_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.lungcan.2015.06.003","volume":"89","author":"K Kadota","year":"2015","unstructured":"Kadota K, Buitrago D, Lee M-C, Villena-Vargas J, Sima CS, Jones DR et al (2015) Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer 89(3):329\u2013336","journal-title":"Lung Cancer"},{"issue":"7","key":"11193_CR22","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/cancers16071280","volume":"16","author":"G Konstantis","year":"2024","unstructured":"Konstantis G, Tsaousi G, Pourzitaki C, Kasper-Virchow S, Zaun G, Kitsikidou E et al (2024) Identification of key genes associated with tumor microenvironment infiltration and survival in gastric adenocarcinoma via bioinformatics analysis. Cancers (Basel) 16(7):1280","journal-title":"Cancers (Basel)"},{"issue":"4","key":"11193_CR23","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA, Ch\u00e1vez-Valencia V, G\u00f3mez-Guijosa M, Cortes-Penagos C (2017) Acute Myeloid Leukemia-Genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res 11(4):328\u2013339","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"1","key":"11193_CR24","first-page":"3726595","volume":"2017","author":"C Leygo","year":"2017","unstructured":"Leygo C, Williams M, Jin HC, Chan MW, Chu WK, Grusch M et al (2017) DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer. Dis Markers 2017(1):3726595","journal-title":"Dis Markers"},{"key":"11193_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0409-z","volume":"10","author":"Y Li","year":"2017","unstructured":"Li Y, Xu Q, Lv N, Wang L, Zhao H, Wang X et al (2017) Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. J Hematol Oncol 10:1\u201310","journal-title":"J Hematol Oncol"},{"issue":"7","key":"11193_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.ajpath.2019.04.007","volume":"189","author":"M Li","year":"2019","unstructured":"Li M, Wang L, Zhan Y, Zeng T, Zhang X, Guan X-Y et al (2019) Membrane Metalloendopeptidase (MME) suppresses metastasis of Esophageal squamous cell carcinoma (ESCC) by inhibiting FAK-RhoA signaling axis. Am J Pathol 189(7):1462\u20131472","journal-title":"Am J Pathol"},{"issue":"11","key":"11193_CR27","doi-asserted-by":"publisher","first-page":"757135","DOI":"10.3389\/fonc.2021.757135","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Guo Q, Zhang J, Fu Z, Wang Y, Wang T et al (2021) The RNA-binding motif protein family in cancer: friend or foe? Front Oncol 11(11):757135","journal-title":"Front Oncol"},{"issue":"2","key":"11193_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/jleuko\/qiac015","volume":"113","author":"Z Li","year":"2023","unstructured":"Li Z, He Z, Wang J, Kong G (2023) RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies. J Leukoc Biol 113(2):149\u2013163","journal-title":"J Leukoc Biol"},{"key":"11193_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JBM.S437400","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Haihui Z, Fenglin L, Ying L, Pei R (2024) Prognostic significance of dual-specificity phosphatase 23 expression in acute myeloid leukemia. J Blood Med 15:35\u201350","journal-title":"J Blood Med"},{"issue":"18","key":"11193_CR30","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMe0802379","volume":"358","author":"B L\u00f6wenberg","year":"2008","unstructured":"L\u00f6wenberg B (2008) Diagnosis and prognosis in acute myeloid Leukemia\u2014the art of distinction. N Engl J Med 358(18):1960\u20131962","journal-title":"N Engl J Med"},{"issue":"14","key":"11193_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B L\u00f6wenberg","year":"1999","unstructured":"L\u00f6wenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341(14):1051\u20131062","journal-title":"N Engl J Med"},{"issue":"1","key":"11193_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/modpathol.3800713","volume":"20","author":"NA Makretsov","year":"2007","unstructured":"Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG (2007) Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 20(1):84\u201389","journal-title":"Mod Pathol"},{"key":"11193_CR33","doi-asserted-by":"publisher","first-page":"4328697","DOI":"10.1155\/2016\/4328697","volume":"2016","author":"D Mishra","year":"2016","unstructured":"Mishra D, Singh S, Narayan G (2016) Role of B cell development marker CD10 in cancer progression and prognosis. Mol Biol Int 2016:4328697","journal-title":"Mol Biol Int"},{"issue":"10","key":"11193_CR34","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1007\/s13277-016-5248-y","volume":"37","author":"M Mizerska-Kowalska","year":"2016","unstructured":"Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szersze\u0144 M (2016) Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development. Tumor Biol 37(10):13355\u201313368","journal-title":"Tumor Biol"},{"issue":"1","key":"11193_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/2277-9175.143241","volume":"3","author":"M Mokhtari","year":"2014","unstructured":"Mokhtari M, Ameri F (2014) Diagnostic value of CD-10 marker in differentiating of papillary thyroid carcinoma from benign thyroid lesions. Adv Biomed Res 3(1):206","journal-title":"Adv Biomed Res"},{"issue":"11","key":"11193_CR36","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1182\/blood.V104.11.1957.1957","volume":"104","author":"A M\u00f6ricke","year":"2004","unstructured":"M\u00f6ricke A, Ratei R, Ludwig W-D, Harbott J, Borkhardt A, Viehmann S et al (2004) Prognostic factors in CD10 negative precursor B-Cell acute lymphoblastic leukemia in children: data from three consecutive trials ALL-BFM 86, 90, and 95. Blood 104(11):1957","journal-title":"Blood"},{"issue":"6","key":"11193_CR37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaad.2010.10.019","volume":"65","author":"J Oba","year":"2011","unstructured":"Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M et al (2011) Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. J Am Acad Dermatol 65(6):1152\u20131160","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"11193_CR38","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND et al (2016) Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med 374(23):2209\u20132221","journal-title":"N Engl J Med"},{"issue":"1","key":"11193_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","volume":"34","author":"MS Pavlyukov","year":"2018","unstructured":"Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y et al (2018) Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing factors. Cancer Cell 34(1):119\u201335.e10","journal-title":"Cancer Cell"},{"issue":"1","key":"11193_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, R\u00f6thlisberger S (2017) Molecular biomarkers in acute myeloid leukemia. Blood Rev 31(1):63\u201376","journal-title":"Blood Rev"},{"key":"11193_CR41","doi-asserted-by":"publisher","first-page":"566024","DOI":"10.3389\/fgene.2020.566024","volume":"11","author":"Y Qu","year":"2020","unstructured":"Qu Y, Zhang S, Qu Y, Guo H, Wang S, Wang X et al (2020) Novel gene signature reveals prognostic model in acute myeloid leukemia. Front Genet 11:566024","journal-title":"Front Genet"},{"issue":"3","key":"11193_CR42","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X (2013) An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3(3):71\u201385","journal-title":"Biostat Bioinforma Biomath"},{"issue":"20","key":"11193_CR43","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2010.32.8500","volume":"29","author":"C R\u00f6llig","year":"2011","unstructured":"R\u00f6llig C, Bornh\u00e4user M, Thiede C, Taube F, Kramer M, Mohr B et al (2011) Long-term prognosis of acute Myeloid Leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol 29(20):2758\u20132765","journal-title":"J Clin Oncol"},{"key":"11193_CR44","doi-asserted-by":"publisher","first-page":"106135","DOI":"10.1016\/j.archoralbio.2024.106135","volume":"170","author":"T Sakurai","year":"2025","unstructured":"Sakurai T, Ishii M, Miyata H, Ikeda N, Suehiro F, Komabashiri N et al (2025) Effect of CD10-positive cells on osteogenic differentiation of human maxillary\/mandibular bone marrow-derived mesenchymal stem cells. Arch Oral Biol 170:106135","journal-title":"Arch Oral Biol"},{"issue":"3\u20134","key":"11193_CR45","doi-asserted-by":"publisher","first-page":"187585922412962","DOI":"10.1177\/18758592241296287","volume":"41","author":"Y Shao","year":"2024","unstructured":"Shao Y, Qin T (2024) High TCTA expression is an adverse prognostic biomarker in acute myeloid leukemia. Cancer Biomark 41(3\u20134):18758592241296290","journal-title":"Cancer Biomark"},{"issue":"1","key":"11193_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/bcj.2015.114","volume":"6","author":"F St\u00f6lzel","year":"2016","unstructured":"St\u00f6lzel F, Mohr B, Kramer M, Oelschl\u00e4gel U, Bochtler T, Berdel WE et al (2016) Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J 6(1):386","journal-title":"Blood Cancer J"},{"issue":"4","key":"11193_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7555\/JBR.38.20240065","volume":"38","author":"J Tang","year":"2024","unstructured":"Tang J, Luo L, Bosco B, Li N, Huang B, Wu R et al (2024) Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis. J Biomed Res 38(4):397\u2013412","journal-title":"J Biomed Res"},{"issue":"1","key":"11193_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","volume":"9","author":"Y Tao","year":"2024","unstructured":"Tao Y, Zhang Q, Wang H, Yang X, Mu H (2024) Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Ther 9(1):26","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"11193_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000087476","volume":"69","author":"M Terauchi","year":"2005","unstructured":"Terauchi M, Kajiyama H, Shibata K, Ino K, Mizutani S, Kikkawa F (2005) Anti-progressive effect of neutral endopeptidase 24.11 (NEP\/CD10) on cervical carcinoma in vitro and in vivo. Oncology 69(1):52\u201362","journal-title":"Oncology"},{"issue":"3","key":"11193_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/105072503321582105","volume":"13","author":"C Tomoda","year":"2003","unstructured":"Tomoda C, Kushima R, Takeuti E, Mukaisho K-i, Hattori T, Kitano H (2003) CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma. Thyroid 13(3):291\u2013295","journal-title":"Thyroid"},{"issue":"546","key":"11193_CR51","doi-asserted-by":"publisher","first-page":"eaaz0463","DOI":"10.1126\/scitranslmed.aaz0463","volume":"12","author":"J Vadakekolathu","year":"2020","unstructured":"Vadakekolathu J, Minden MD, Hood T, Church SE, Reeder S, Altmann H et al (2020) Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia. Sci Transl Med 12(546):eaaz0463","journal-title":"Sci Transl Med"},{"key":"11193_CR52","doi-asserted-by":"publisher","first-page":"109876","DOI":"10.1016\/j.biopha.2020.109876","volume":"125","author":"N Wang","year":"2020","unstructured":"Wang N, Lu K, Qu H, Wang H, Chen Y, Shan T et al (2020) CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. Biomed Pharmacother 125:109876","journal-title":"Biomed Pharmacother"},{"key":"11193_CR53","doi-asserted-by":"publisher","first-page":"1336310","DOI":"10.3389\/fphar.2024.1336310","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Xiao Y, An X, Luo L, Gong K, Yu D (2024) A comprehensive review of the literature on CD10: its function, clinical application, and prospects. Front Pharmacol 15:1336310","journal-title":"Front Pharmacol"},{"issue":"11","key":"11193_CR54","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1016\/j.celrep.2019.08.012","volume":"28","author":"CRM Wiggers","year":"2019","unstructured":"Wiggers CRM, Baak ML, Sonneveld E, Nieuwenhuis EES, Bartels M, Creyghton MP (2019) AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. Cell Rep 28(11):2866\u201377.e5","journal-title":"Cell Rep"},{"issue":"S1","key":"11193_CR55","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/cyto.b.20363","volume":"72","author":"BL Wood","year":"2007","unstructured":"Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ et al (2007) 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytom Part B: Clin Cytom: J Int Soc Anal Cytol 72(S1):S14\u2013S22","journal-title":"Cytom Part B: Clin Cytom: J Int Soc Anal Cytol"},{"issue":"1","key":"11193_CR56","first-page":"42","volume":"127","author":"BJ Wouters","year":"2016","unstructured":"Wouters BJ, Delwel R (2016) Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood, J Am Soc Hematol 127(1):42\u201352","journal-title":"Blood, J Am Soc Hematol"},{"issue":"7","key":"11193_CR57","doi-asserted-by":"publisher","first-page":"8956","DOI":"10.1002\/cam4.5549","volume":"12","author":"Z Wu","year":"2023","unstructured":"Wu Z, Ou J, Liu N, Wang Z, Chen J, Cai Z et al (2023) Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia. Cancer Med 12(7):8956\u20138969","journal-title":"Cancer Med"},{"key":"11193_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41523-020-00200-w","volume":"6","author":"PW Xi","year":"2020","unstructured":"Xi PW, Zhang X, Zhu L, Dai XY, Cheng L, Hu Y et al (2020) Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer. NPJ Breast Cancer 6:58","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"11193_CR59","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00262-019-02408-7","volume":"68","author":"H Yan","year":"2019","unstructured":"Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E et al (2019) Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother 68(12):1971\u20131978","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"11193_CR60","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.3109\/10428194.2012.684350","volume":"53","author":"Y Yang","year":"2012","unstructured":"Yang Y, Wang S, Zhang Y, Zhu X (2012) Biological effects of decreasing RBM15 on chronic myelogenous leukemia cells. Leuk Lymphoma 53(11):2237\u20132244","journal-title":"Leuk Lymphoma"},{"key":"11193_CR61","doi-asserted-by":"publisher","first-page":"807410","DOI":"10.3389\/fonc.2021.807410","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Hong S, Zhang X, Liu J, Wang Y, Wang Z et al (2021) Tumor immune microenvironment related gene-based model to predict prognosis and response to compounds in ovarian cancer. Front Oncol 11:807410","journal-title":"Front Oncol"},{"issue":"1","key":"11193_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13046-018-0852-x","volume":"37","author":"J Ye","year":"2018","unstructured":"Ye J, Liang R, Bai T, Lin Y, Mai R, Wei M et al (2018) RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma. J Exp Clin Cancer Res 37(1):212","journal-title":"J Exp Clin Cancer Res"},{"key":"11193_CR63","doi-asserted-by":"publisher","first-page":"608932","DOI":"10.3389\/fonc.2021.608932","volume":"11","author":"C Yin","year":"2021","unstructured":"Yin C, Zhang J, Guan W, Dou L, Liu Y, Shen M et al (2021) High expression of CLEC11A predicts favorable prognosis in acute myeloid leukemia. Front Oncol 11:608932","journal-title":"Front Oncol"},{"issue":"6","key":"11193_CR64","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA et al (2022) A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med 28(6):1212\u20131223","journal-title":"Nat Med"},{"issue":"8","key":"11193_CR65","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1080\/10428194.2020.1742898","volume":"61","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao L (2020) Identification and validation of a prognostic 8-gene signature for acute myeloid leukemia. Leuk Lymphoma 61(8):1981\u20131988","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"11193_CR66","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1101\/gad.2069311","volume":"25","author":"J Zhang","year":"2011","unstructured":"Zhang J, Cho S-J, Shu L, Yan W, Guerrero T, Kent M et al (2011) Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas. Genes Dev 25(14):1528\u20131543","journal-title":"Genes Dev"},{"issue":"52","key":"11193_CR67","doi-asserted-by":"publisher","first-page":"18637","DOI":"10.1073\/pnas.1415607112","volume":"111","author":"J Zhang","year":"2014","unstructured":"Zhang J, Xu E, Ren C, Yan W, Zhang M, Chen M et al (2014) Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors. Proc Natl Acad Sci 111(52):18637\u201318642","journal-title":"Proc Natl Acad Sci"},{"key":"11193_CR68","doi-asserted-by":"publisher","first-page":"578933","DOI":"10.3389\/fonc.2020.578933","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ma S, Wang M, Shi W, Hu Y (2020) Comprehensive analysis of prognostic markers for acute myeloid leukemia based on four metabolic genes. Front Oncol 10:578933","journal-title":"Front Oncol"},{"issue":"3","key":"11193_CR69","first-page":"1495","volume":"42","author":"X Zhao","year":"2018","unstructured":"Zhao X, Li Y, Wu H (2018) A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Int J Mol Med 42(3):1495\u20131507","journal-title":"Int J Mol Med"},{"issue":"1","key":"11193_CR70","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12920-021-01085-9","volume":"14","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Wu W, Lin Z, Liu S, Chen Q, Jiang X et al (2021) Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. BMC Med Genomics 14(1):236","journal-title":"BMC Med Genomics"},{"issue":"1","key":"11193_CR71","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1080\/21655979.2021.1956400","volume":"12","author":"H Zhou","year":"2021","unstructured":"Zhou H, Xiaofeng J, Fan Y, Shi P (2021) miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6). Bioengineered 12(1):4508\u20134519","journal-title":"Bioengineered"},{"issue":"1","key":"11193_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12859-023-05148-9","volume":"24","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, He J, Li Z, Yang W (2023) Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. BMC Bioinform 24(1):37","journal-title":"BMC Bioinform"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11193-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:02:13Z","timestamp":1779184933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["11193"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11193-1","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was conducted according to the ethics committee of the Zanjan University of Medical Science with ID: IR.ZUMS.BLC.1403.075. All individuals signed written informed consent to engage in this study. The aforementioned ethics committee sanctioned this consent procedure. All personal information about the samples involved in the investigation was anonymized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}